Diagnosis and Treatment of Ovarian Cancer.
Orr B, Edwards RP.
Hematol Oncol Clin North Am. 2018 Dec;32(6):943-964. doi: 10.1016/j.hoc.2018.07.010.
Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review.
van Stein RM, Aalbers AGJ, Sonke GS, van Driel WJ.
JAMA Oncol. 2021 Aug 1;7(8):1231-1238. doi: 10.1001/jamaoncol.2021.0580.
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.
Aronson SL, Lopez-Yurda M, Koole SN, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van Gent MDJM, Arts HJG, van Ham MAPC, van Dam PA, Vuylsteke P, Aalbers AGJ, Verwaal VJ, Van de Vijver KK, Aaronson NK, Sonke GS, van Driel WJ.
Lancet Oncol. 2023 Oct;24(10):1109-1118. doi: 10.1016/S1470-2045(23)00396-0. Epub 2023 Sep 11.
Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.
Böhm S, Faruqi A, Said I, Lockley M, Brockbank E, Jeyarajah A, Fitzpatrick A, Ennis D, Dowe T, Santos JL, Cook LS, Tinker AV, Le ND, Gilks CB, Singh N.
J Clin Oncol. 2015 Aug 1;33(22):2457-63. doi: 10.1200/JCO.2014.60.5212. Epub 2015 Jun 29.
TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7).
Reuss A, du Bois A, Harter P, Fotopoulou C, Sehouli J, Aletti G, Guyon F, Greggi S, Mosgaard BJ, Reinthaller A, Hilpert F, Schade-Brittinger C, Chi DS, Mahner S.
Int J Gynecol Cancer. 2019 Oct;29(8):1327-1331. doi: 10.1136/ijgc-2019-000682. Epub 2019 Aug 15.
[Peritoneal carcinomatosis].
Königsrainer I, Beckert S, Lehmann T, Ladurner R, Brücher B, Königsrainer A.
Chirurg. 2011 Apr;82(4):375-80; quiz 381. doi: 10.1007/s00104-010-2049-5.
Upper Abdominal Resections as Part of Tertiary Cytoreduction for Relapsed Ovarian Cancer.
Bacalbasa N, Balescu I, Vilcu M, Dima S, Brezean I.
In Vivo. 2020 Jan-Feb;34(1):407-411. doi: 10.21873/invivo.11789.
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
Koole S, van Stein R, Sikorska K, Barton D, Perrin L, Brennan D, Zivanovic O, Mosgaard BJ, Fagotti A, Colombo PE, Sonke G, Driel WJV; OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group.
Int J Gynecol Cancer. 2020 Jun;30(6):888-892. doi: 10.1136/ijgc-2020-001231. Epub 2020 Mar 23.
The hepatic bridge.
Sugarbaker PH.
Eur J Surg Oncol. 2018 Jul;44(7):1083-1086. doi: 10.1016/j.ejso.2018.03.031. Epub 2018 Apr 11.
The role of radiotherapy in ovarian cancer.
Durno K, Powell ME.
Int J Gynecol Cancer. 2022 Mar;32(3):366-371. doi: 10.1136/ijgc-2021-002462.
